Evidence map›Paper›PMID 27124661›Full record

ArticlePloS one2016

Liver-Specific Deletion of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Significantly Ameliorates Chronic EtOH-Induced Increases in Hepatocellular Damage.

Colin T Shearn, David J Orlicky, Rebecca L McCullough, Hua Jiang, Kenneth N Maclean, Kelly E Mercer, Bangyan L Stiles, Laura M Saba, Martin J Ronis, Dennis R Petersen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Sphingolipids and the link between alcohol and cancer.Chemico-biological interactions · 2020
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. PTEN: Tumor Suppressor and Metabolic Regulator.Frontiers in endocrinology · 2018
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Colin T ShearnSkaggs School of Pharmaceutical Sciences and Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.ORCID 0000-0002-9618-9885
David J OrlickyDepartment of Pathology, School of Medicine University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
Rebecca L McCulloughSkaggs School of Pharmaceutical Sciences and Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
Hua JiangDepartment of Pediatrics, School of Medicine University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
Kenneth N MacleanDepartment of Pediatrics, School of Medicine University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
Kelly E MercerArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AK, United States of America.
Bangyan L StilesDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, United States of America.
Laura M SabaSkaggs School of Pharmaceutical Sciences and Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
Martin J RonisArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AK, United States of America.
Dennis R PetersenSkaggs School of Pharmaceutical Sciences and Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
University of Colorado Anschutz Medical Campus · USArkansas Children's Nutrition Center · USUniversity of Southern California · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 1995 to 2026
$32.6M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
Lipid Aldehyde and Ethanol Induced Liver DamageR37AA009300 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI PETERSEN, DENNIS · 2008 to 2017
$4.4M
The role of PTEN and AKT2 in the malignant transformation of liver progenitor celR01CA154986 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI STILES, BANGYAN · 2013 to 2017
$1.7M
Regulation of PTEN in chronic alcohol mediated liver diseaseF32AA018613 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI SHEARN, COLIN · 2010 to 2012
$177k
NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA154986NCRR NIH HHS UL1 RR025780NIAAA NIH HHS F32 AA018613NIAAA NIH HHS R37 AA009300NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

Alcoholic liver disease is a significant contributor to global liver failure. In murine models, chronic ethanol consumption dysregulates PTEN/Akt signaling. Hepatospecific deletion of phosphatase and tensin homolog deleted on chromosome 10 (PTENLKO) mice possess constitutive activation of Akt(s) and increased de novo lipogenesis resulting in increased hepatocellular steatosis. This makes PTENLKO a viable model to examine the effects of ethanol in an environment of preexisting steatosis. The aim of this study was to determine the impact of chronic ethanol consumption and the absence of PTEN (PTENLKO) compared to Alb-Cre control mice (PTENf/f) on hepatocellular damage as evidenced by changes in lipid accumulation, protein carbonylation and alanine amino transferase (ALT). In the control PTENf/f animals, ethanol significantly increased ALT, liver triglycerides and steatosis. In contrast, chronic ethanol consumption in PTENLKO mice decreased hepatocellular damage when compared to PTENLKO pair-fed controls. Consumption of ethanol elevated protein carbonylation in PTENf/f animals but had no effect in PTENLKO animals. In PTENLKO mice, overall hepatic mRNA expression of genes that contribute to GSH homeostasis as well as reduced glutathione (GSH) and oxidized glutathione (GSSG) concentrations were significantly elevated compared to respective PTENf/f counterparts. These data indicate that during conditions of constitutive Akt activation and steatosis, increased GSH homeostasis assists in mitigation of ethanol-dependent induction of oxidative stress and hepatocellular damage. Furthermore, data herein suggest a divergence in EtOH-induced hepatocellular damage and increases in steatosis due to polyunsaturated fatty acids downstream of PTEN.

Indexed as

Alanine TransaminaseAlcohol DrinkingAnimalsChemical and Drug Induced Liver Injury, ChronicDisease Models, AnimalEthanolFatty Acids, UnsaturatedFatty Liver, AlcoholicFemaleGene Expression RegulationGlutathioneLipogenesisLiverMaleMiceMice, KnockoutAlanine TransaminaseEthanolFatty Acids, UnsaturatedGlutathioneProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, mouseTriglycerides

Identifiers

PMID27124661
PMCPMC4849752
OpenAlexW2342765561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.